Market Uncertainty, Surprising Earnings, and ...

It hasn’t been in many headlines (thanks, AI), but pharmaceutical companies are on a merger & acquisition spree that could break records. With more than $126 billion in deals so far this year, companies are looking for novel drug canddiates and clinical stage companies to bolster ...  Show more

The Hidden Gems investing team dissects the big weekend for Toy Story 5 and which stocks could be winners with a resurgent box office. From there Jon, Matt, and Rachel look at how natural gas is poised to power data centers before ending on a listener’s question regarding value i ...  Show more

Carl Quintanilla, David Faber and Mike Santoli began the show with wholesale inflation data that helped to spark a market rally: The Producer Price Index for October came in tamer than expected, unchanged from the previous month when you strip out food and energy. As for retail e ...  Show more

Jim Cramer and David Faber took an in-depth look at a busy day for the markets with a slew of earnings reports in the mix -- as stocks recouped all of their losses from Monday's sell-off. Dow components Coca-Cola, Johnson & Johnson and Verizon all beating analyst expectations wit ...  Show more

This week on Prof G Markets, Scott deciphers the market’s disparate responses to strong earnings announcements from Uber and Airbnb, and what it tells us about the importance of the narrative over numbers in stock valuation. Then we take a deep dive into Apple’s surprisingly larg ...  Show more

Investors are awaiting the kickoff to this week's Fed decision. The Milken Institute's Bill Lee gives his expectations. Plus, Amazon and Apple are set to deliver results in what could be two market-moving events. Janus Henderson's Alison Porter explains. And, it's busiest week ...